Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
Immunotherapy has dramatically changed the therapeutic landscape of oncology, and has become standard of care in multiple cancer types in front or late lines of therapy, with some longstanding responses and outstanding results. Notwithstanding, its use has brought a totally unique spectrum of advers...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2022-08-01
|
| Saila: | Diagnostics |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2075-4418/12/9/2091 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|